Johnson & Johnson has officially completed its acquisition of Halda Therapeutics OpCo, Inc., a clinical-stage biotechnology company known for its innovative cancer-targeting technology, in a deal valued at USD 3.05 billion in cash.
Enveric Biosciences, a biotechnology company developing next-generation small-molecule neuroplastogenic therapeutics, announced the issuance of a significant new U.S. patent that enhances its intellectual property portfolio and expands opportunities for advancing treatments in mental health disorders.
The Central Government has officially banned the manufacture, sale, and distribution of all oral formulations containing nimesulide above 100 mg in immediate-release dosage form for human use across India.
Postgraduate degree in Chemistry from a recognized University/Institution Or MPharm with Pharmaceutical Chemistry from a recognized University / Institution
Masters degree in Pharmacy / Engineering / Technology / Science or equivalent degree in Materials / Nanotechnology / Biotechnology or allied branches with a qualified GPAT / GATE / NET.
PhD or equivalent degree OR three years of research, teaching, design and development after MVSc / M.Pharm / M.E/ M.Tech with at least one research paper in Science Citation Index.
Responsible for executing technology transfer activities for injectable dosage forms, including planning and performing Scale-up, Exhibit and Process Validation batches with optimal utilization of manpower, materials, and equipment.
Kusum Healthcare Pvt. Ltd. is a part of the Kusum group of companies which is a fully integrated, young pharmaceutical group having three manufacturing units
A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a compound derived from the traditional Chinese herb Salvia miltiorrhiza, on ovarian cancer. The research, conducted by a team from Zhejiang Chinese Medical University and Jiangsu Normal University, reveals that DHT can induce autophagic cell death in ovarian cancer cells by disrupting the sortilin 1 (SORT1)-mediated autophagy–lysosome pathway.
A Diploma in Pharmacy or Bachelor of Pharmacy or Pharm.D, Must have registered with State Pharmacy Council and must keep the registration alive renewing it regularly every year.